Brief: India's Mangalam Drugs And Organics Receives Final Approval From WHO For Efavirenz
Sept 24 (Reuters) - Mangalam Drugs and Organics Ltd
MADR.NS :
* SAYS CO RECEIVES FINAL APPROVAL FROM WHO FOR THE DRUG
EFAVIRENZ
Source: https://bit.ly/2Q3vwM7
Further company coverage: MADR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mangalam Drugs and Organics
See all newsBrief: Mangalam Drugs And Organics Ltd Defaulted On Loan Obligations To Bank Of Baroda And Bank Of Maharashtra
Brief: Mangalam Drugs And Organics Defaults On Loans Obligations To Bank Of Baroda And Bank Of Maharashtra Over 30 Days
Brief: Mangalam Drugs And Organics Defaults On Loan Obligations To Bank Of Baroda, Bank Of Maharashtra
Brief: Mangalam Drugs And Organics Names Jeevan M. Dalvi As CFO
Brief: Mangalam Drugs And Organics Gets Order Worth 150 Million Rupees